NASDAQ : TNON
Tenon Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 2.29 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.33M |
| Enterprise Value | 5.34M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 667,047 |
| Shares Outstanding | 667,047 |
| Shares Change (YoY) | +169.77% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 4.84% |
| Owned by Institutions (%) | 6.62% |
| Float | 613,867 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | 0.20 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.58 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -551.19% |
| Return on Assets (ROA) | -71.98% |
| Return on Invested Capital (ROIC) | -138.43% |
| Return on Capital Employed (ROCE) | -749.10% |
| Weighted Average Cost of Capital (WACC) | 13.80% |
| Revenue Per Employee | $204,308 |
| Profits Per Employee | -$526,808 |
| Employee Count | 26 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -95.06% |
| 50-Day Moving Average | 3.58 |
| 200-Day Moving Average | 16.94 |
| Relative Strength Index (RSI) | 34.13 |
| Average Volume (20 Days) | 177,995 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 51,800 |
| Short Previous Month | 60,789 |
| Short % of Shares Out | 7.77% |
| Short % of Float | 8.44% |
| Short Ratio (days to cover) | 0.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.31M |
| Gross Profit | 3.55M |
| Operating Income | -12.11M |
| Pretax Income | -13.70M |
| Net Income | -13.70M |
| EBITDA | -11.80M |
| EBIT | -12.11M |
| Loss Per Share | -$46.67 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.68M |
| Total Debt | 5.68M |
| Net Cash | -4.00M |
| Net Cash Per Share | -$6.00 |
| Equity (Book Value) | -1.74M |
| Book Value Per Share | -14.57 |
| Working Capital | -3.50M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -11.77M |
| Capital Expenditures | -1.06M |
| Depreciation & Amortization | 315,000 |
| Net Borrowing | 4.30M |
| Free Cash Flow | -12.83M |
| FCF Per Share | -$19.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 66.81% |
| Operating Margin | -228.03% |
| Pretax Margin | -257.85% |
| Profit Margin | -257.85% |
| EBITDA Margin | -222.10% |
| EBIT Margin | -228.03% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -169.77% |
| Shareholder Yield | -169.77% |
| Earnings Yield | -2,333.62% |
| FCF Yield | -937.88% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $10.50 |
| Price Target Difference | 425.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 66.22% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -15.96 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |